This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1996 Jun;39(2):436-50.

doi: 10.1097/00003081-199606000-00017.

Mifepristone: clinical pharmacology

A Robbins¹, I M Spitz

Affiliations

PMID: 8734008
DOI: 10.1097/00003081-199606000-00017

Review

Mifepristone: clinical pharmacology

A Robbins et al. Clin Obstet Gynecol. 1996 Jun.

. 1996 Jun;39(2):436-50.

doi: 10.1097/00003081-199606000-00017.

Authors

A Robbins¹, I M Spitz

Affiliation

¹ Population Council Center for Biomedical Research, New York, New York 10021, USA.

PMID: 8734008
DOI: 10.1097/00003081-199606000-00017

No abstract available

PubMed Disclaimer

Similar articles

New-D-homoandrost-4,6-diene derivatives as potent progesterone receptor antagonist.
Cabeza M, García-Lorenzana M, Garcés M, Heuze I, Teran N, Bratoeff E. Cabeza M, et al. Steroids. 2010 Jan;75(1):101-8. doi: 10.1016/j.steroids.2009.11.001. Epub 2009 Nov 12. Steroids. 2010. PMID: 19913568
Antiprogestins: mechanism of action and contraceptive potential.
Spitz IM, Croxatto HB, Robbins A. Spitz IM, et al. Annu Rev Pharmacol Toxicol. 1996;36:47-81. doi: 10.1146/annurev.pa.36.040196.000403. Annu Rev Pharmacol Toxicol. 1996. PMID: 8725382 Review.
Novel phosphorus-containing 17beta-side chain mifepristone analogues as progesterone receptor antagonists.
Jiang W, Allan G, Chen X, Fiordeliso JJ, Linton O, Tannenbaum P, Xu J, Zhu P, Gunnet J, Demarest K, Lundeen S, Sui Z. Jiang W, et al. Steroids. 2006 Nov;71(11-12):949-54. doi: 10.1016/j.steroids.2006.07.003. Epub 2006 Aug 28. Steroids. 2006. PMID: 16934845
Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.
Kannan A, Bhurke A, Sitruk-Ware R, Lalitkumar PG, Gemzell-Danielsson K, Williams ARW, Taylor RN, Bagchi MK, Bagchi IC. Kannan A, et al. Reprod Sci. 2018 Mar;25(3):320-328. doi: 10.1177/1933719117746764. Epub 2017 Dec 14. Reprod Sci. 2018. PMID: 29241443 Free PMC article.
Progesterone receptor antagonists.
Spitz IM. Spitz IM. Curr Opin Investig Drugs. 2006 Oct;7(10):882-90. Curr Opin Investig Drugs. 2006. PMID: 17086932 Review.

See all similar articles

Cited by

Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone.
McCartney CR, Blank SK, Marshall JC. McCartney CR, et al. Endocrine. 2009 Oct;36(2):239-45. doi: 10.1007/s12020-009-9215-x. Epub 2009 Jul 16. Endocrine. 2009. PMID: 19609733 Free PMC article. Clinical Trial.
Off-label use of misoprostol in gynaecology.
Turner JV, Agatonovic-Kustrn S, Ward H. Turner JV, et al. Facts Views Vis Obgyn. 2015 Dec 28;7(4):261-264. Facts Views Vis Obgyn. 2015. PMID: 27729972 Free PMC article.
Proven and potential clinical applications of mifpristone (RU486).
Spitz IM. Spitz IM. Rev Endocr Metab Disord. 2002 Sep;3(3):267-75. doi: 10.1023/a:1020032711706. Rev Endocr Metab Disord. 2002. PMID: 12215721 Review. No abstract available.
Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility.
Islam MS, Afrin S, Jones SI, Segars J. Islam MS, et al. Endocr Rev. 2020 Oct 1;41(5):bnaa012. doi: 10.1210/endrev/bnaa012. Endocr Rev. 2020. PMID: 32365199 Free PMC article. Review.
In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment.
Zarezade V, Abolghasemi M, Rahim F, Veisi A, Behbahani M. Zarezade V, et al. J Mol Model. 2018 Nov 10;24(12):337. doi: 10.1007/s00894-018-3858-6. J Mol Model. 2018. PMID: 30415281

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- The Lens - Patent Citations Database